C98 displays robust activity against the PI3K/AKT signals which is critical for cell proliferation and cell survival, therefore C98 treatment led to growth inhibition and apoptosis of multiple MM cell lines. The gene discussed is AKT1; the disease is Miyoshi myopathy.